Media Releases

2020

15/06/2020

Big pharma clinical study validates PromarkerD kidney test

25/05/2020

Proteomics International receives COVID-19 research grants

16/04/2020

CE Mark for PromarkerD Immunoassay Kit

07/04/2020

Diagnostics R&D expanded: the Promarker™ Pipeline

31/03/2020

Proteomics International expands study with US big pharma

23/03/2020

Proteomics International to patent biomarkers for diagnosis of endometriosis

23/03/2020

WA company takes further step towards blood test for endometriosis

10/02/2020

PromarkerD presented at Australasian Proteomics conference

14/01/2020

CE Mark for PromarkerD Hub predictive software for DKD

2019

26/11/2019

Cutting-edge Protein Biomarker Analysis Facility for Western Australia

15/11/2019

Proteomics International raises $3m in heavily oversubscribed Placement

12/11/2019

CE Mark for predictive test for diabetic kidney disease

29/10/2019

Proteomics receives $1.1 million in R&D tax incentive

17/09/2019

PromarkerD IVD successfully developed and validated

13/09/2019

PromarkerD showcased at EASD

Newsroom

News Archive

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Subscribe
  • This field is for validation purposes and should be left unchanged.
Menu